The significance of PLA2G7 is evident across a range of metabolic and inflammatory diseases, including atherosclerosis (Casas et al., 2010), diabetes (Canning et al., 2016), and autoimmune disorders (Li et al., 2021). Here, PLA2G7 is linked to atherosclerosis.